Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)

Clinical trial NCT04901325 · COMPLETED

Trial details

NCT number: NCT04901325
Sponsor: Oregon Health and Science University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pyoderma Gangrenosum Skin Diseases Wound Heal Pyoderma Skin Ulcer

Start date: 2023-10-03
Primary completion: 2025-01-05
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.